Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2021-01-25 Major Shareholding Noti…
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-25 English
PRIMARY DOCUMENT
Director's Dealing
2021-01-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated December 21, 2020. It includes a product update regarding an FDA Emergency Use Authorization application and an updated investor presentation attached as exhibits. The text explicitly states that the investor presentation is attached as Exhibit 99.3 and will be available on the company's website. The document is a regulatory filing announcing updates and furnishing an investor presentation, but it is not the investor presentation itself nor a full financial report. The length is about 4993 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document is best classified as a Regulatory Filing (RNS) because it is a current report providing updates and attaching materials, not the full investor presentation or a financial report.
2020-12-21 English
PRIMARY DOCUMENT
Director's Dealing
2020-12-21 English
8-K
Investor Presentation Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 5, 2020, by OraSure Technologies, Inc. The key content is the furnishing of an Investor Presentation attached as Exhibit 99.1. The text explicitly states that the presentation is attached and available on the company's website, and the document itself is a short report (4222 characters) primarily announcing the availability of the investor presentation. There are no detailed financial statements or substantive financial data within this document itself. According to the 'Menu vs Meal' rule, this is an announcement of a report (the investor presentation), not the report itself. Therefore, the correct classification is Investor Presentation (IP).
2020-11-05 English
10-Q
Interim / Quarterly Report 9M 2020
2020-11-05 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.